{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:32:24Z","timestamp":1777303944990,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR4051"],"award-info":[{"award-number":["SHDC2020CR4051"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016108","name":"Shanghai Baoshan Science and Technology Commission","doi-asserted-by":"publisher","award":["21-E-63"],"award-info":[{"award-number":["21-E-63"]}],"id":[{"id":"10.13039\/501100016108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009002","name":"Shanghai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jep.2026.121578","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:41:18Z","timestamp":1774658478000},"page":"121578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Danggui-Shaoyao-San ameliorates metabolic dysfunction-associated steatohepatitis via suppressing hepatic macrophage NLRP3 inflammasome"],"prefix":"10.1016","volume":"366","author":[{"given":"Qian","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziming","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2026.121578_bib1","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","article-title":"Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis","volume":"73","author":"Babuta","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jep.2026.121578_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110985","article-title":"Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases","volume":"133","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2026.121578_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jep.2026.121578_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00018-024-05328-7","article-title":"Targeting BRD4 mitigates hepatocellular lipotoxicity by suppressing the NLRP3 inflammasome activation and GSDMD-mediated hepatocyte pyroptosis","volume":"81","author":"Chen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jep.2026.121578_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1573409918666220815093324","article-title":"Investigation of the potential mechanism of Danggui Shaoyao San for the treatment of non-alcoholic fatty liver disease (NAFLD) with network pharmacology and molecular docking","volume":"18","author":"Cheng","year":"2022","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.jep.2026.121578_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2026.121578_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jep.2026.121578_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12272-021-01342-6","article-title":"Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics","volume":"44","author":"Deng","year":"2021","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.jep.2026.121578_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2018.05.108","article-title":"Dangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs\/NF-\u03baB signaling pathway","volume":"105","author":"Ding","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2026.121578_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.14336\/AD.2015.1220","article-title":"Danggui-Shaoyao-San: New hope for Alzheimer's disease","volume":"7","author":"Fu","year":"2015","journal-title":"Aging Dis"},{"key":"10.1016\/j.jep.2026.121578_bib11","first-page":"1069","article-title":"Dose conversion among different animals and healthy volunteers in pharmacological study","volume":"9","author":"Huang","year":"2004","journal-title":"Chin. J. Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.jep.2026.121578_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154797","article-title":"A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage","volume":"120","author":"Huang","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2026.121578_bib13","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.apsb.2022.05.001","article-title":"Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: a promising drug Potentilla discolor Bunge","volume":"12","author":"Ji","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2026.121578_bib14","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/hep.31167","article-title":"Hepatic deficiency of augmenter of liver regeneration predisposes to nonalcoholic steatohepatitis and fibrosis","volume":"72","author":"Kumar","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.121578_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jep.2012.02.050","article-title":"Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice","volume":"141","author":"Lan","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121578_bib16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-Mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jep.2026.121578_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156043","article-title":"Comparative efficacy of THR-\u03b2 agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: a systematic review and network meta-analysis","volume":"161","author":"Lin","year":"2024","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.jep.2026.121578_bib18","article-title":"Loss of stearoyl-CoA desaturase 2 disrupts inflammatory response in macrophages","volume":"14","author":"Lin","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.jep.2026.121578_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154289","article-title":"Atractylenolide III from Atractylodes macrocephala Koidz promotes the activation of brown and white adipose tissue through SIRT1\/PGC-1\u03b1 signaling pathway","volume":"104","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2026.121578_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2026.121578_bib21","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jep.2026.121578_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/mt.2010.258","article-title":"Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration","volume":"19","author":"Maclachlan","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jep.2026.121578_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-024-06306-1","article-title":"Targeting the NLRP3 inflammasome-IL-1\u03b2 pathway in type 2 diabetes and obesity","volume":"68","author":"Meier","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.jep.2026.121578_bib24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/hepr.12883","article-title":"Hepatic nucleotide binding oligomerization domain-like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease","volume":"47","author":"Mitsuyoshi","year":"2017","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jep.2026.121578_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2026.121578_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ptr.3602","article-title":"Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid","volume":"26","author":"Oi","year":"2012","journal-title":"Phytother Res."},{"key":"10.1016\/j.jep.2026.121578_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115861","article-title":"NLRP3 inflammasome in hepatic diseases: a pharmacological target","volume":"217","author":"Ramos-Tovar","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jep.2026.121578_bib28","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.121578_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2026.121578_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2026.121578_bib31","article-title":"Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma","volume":"5","author":"Talamantes","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jep.2026.121578_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1476419","article-title":"Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice","volume":"11","author":"Tao","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.jep.2026.121578_bib33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.jep.2026.121578_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2026.121578_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115736","article-title":"Danggui Shaoyao San ameliorates the lipid metabolism via the PPAR signaling pathway in a Danio rerio (zebrafish) model of hyperlipidemia","volume":"168","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2026.121578_bib36","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2026.121578_bib37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.121578_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.phymed.2011.05.002","article-title":"Anti-depression effects of Danggui-Shaoyao-San, a fixed combination of Traditional Chinese Medicine, on depression model in mice and rats","volume":"18","author":"Xu","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2026.121578_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jep.2026.121578_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671708","article-title":"Danggui-Shaoyao-San improves gut microbia dysbiosis and hepatic lipid homeostasis in fructose-fed rats","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2026.121578_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154589","article-title":"Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2026.121578_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116870","article-title":"Danggui Shaoyao San: chemical characterization and inhibition of oxidative stress and inflammation to treat CCl4-induced hepatic fibrosis","volume":"318","author":"Zhao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121578_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117383","article-title":"Bile acids metabolism involved in the beneficial effects of Danggui Shaoyao San via gut microbiota in the treatment of CCl4 induced hepatic fibrosis","volume":"319","author":"Zhao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121578_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41575-024-00959-4","article-title":"Food inequity and insecurity and MASLD: burden, challenges, and interventions","volume":"21","author":"Zelber-Sagi","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126004290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126004290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:32:35Z","timestamp":1777300355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126004290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"alternative-id":["S0378874126004290"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.121578","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danggui-Shaoyao-San ameliorates metabolic dysfunction-associated steatohepatitis via suppressing hepatic macrophage NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.121578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121578"}}